Gastroenterology and Metabology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan.
Hepato-Biliary-Pancreatic Surgery and Breast Surgery, Ehime University Graduate School of Medicine, Toon, Ehime, Japan.
BMC Gastroenterol. 2020 Apr 6;20(1):92. doi: 10.1186/s12876-020-01226-x.
Endoscopic balloon dilation and/or plastic stent placement has been a standard method for treating biliary strictures complicated post living donor liver transplantation (LDLT). The strictures may be refractory to endoscopic treatment and require long-term stent placement. However, consensus on the optimal period of the stent indwelling and usefulness of the inside stent does not exist.
We evaluated the long-term efficacy of stent treatment in patients with biliary stricture post LDLT. In addition, we compared the stent patency between inside stent and conventional outside stent.
A total of 98 ERC sessions (median 6: range 1-14) performed on 16 patients receiving endoscopic treatment for biliary strictures post LDLT with duct-to-duct biliary reconstruction were analyzed. Biliary strictures successfully treated in 14 patients (88%) included 7 patients (44%) showing improvement of biliary strictures with repeated endoscopic stent placement. Stent replacement was carried out every 6 to 12 months for the remainder 7 patients (44%). Biliary stents were placed in 87 sessions (77 inside sessions and 10 outside sessions). Stent migration occurred 13 times (16%) and none of the inside stent sessions and the outside stent sessions, respectively. Median patency of inside stent and outside stent were 222 days (range; 8-1736) and 99 days (range; 7-356), respectively. The stent occlusion was significantly less in inside stent than in outside stent (p < 0.001). Stone formation was observed in 14 (18%) of the inside stent and 3 (30%) of the outside stent. Biliary stones were small and successfully removed endoscopically.
The endoscopic treatment using inside stent was useful in the management of biliary strictures after LDLT.
内镜下球囊扩张和/或塑料支架置入术已成为治疗肝移植术后(LDLT)胆管狭窄的标准方法。这些狭窄可能对内镜治疗有抗性,需要长期支架置入。然而,对于支架留置的最佳时间和支架内的有效性尚未达成共识。
我们评估了支架治疗在 LDLT 后胆管狭窄患者中的长期疗效。此外,我们比较了支架内支架和传统外支架的通畅性。
共分析了 16 例接受 LDLT 后胆管狭窄内镜治疗的患者 98 次 ERC 治疗(中位数 6:范围 1-14),胆管吻合采用胆管对胆管重建。14 例(88%)患者的胆管狭窄成功治疗,其中 7 例(44%)通过反复内镜支架置入改善了胆管狭窄。其余 7 例(44%)患者每 6-12 个月更换一次支架。在 87 次支架置入中(77 次支架内,10 次支架外),支架移位 13 次(16%),支架内和支架外均未发生支架移位。支架内和支架外的中位通畅时间分别为 222 天(范围 8-1736)和 99 天(范围 7-356)。支架内支架闭塞明显少于支架外支架(p<0.001)。支架内有 14 例(18%)和支架外有 3 例(30%)形成结石。胆管结石较小,内镜下成功取出。
支架内支架治疗在 LDLT 后胆管狭窄的管理中是有用的。